Effects of N-acetylcysteine on brain glutamate levels and resting perfusion in schizophrenia.
2018
Rationale
N-Acetylcysteine (NAC) is currently under investigation as an adjunctive treatment for schizophrenia. The therapeutic potential of NAC may involve modulation of brain glutamate function, but its effects on brain glutamate levels in schizophrenia have not been evaluated.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
71
References
16
Citations
NaN
KQI